2025-03-26.md 2.4 KB
2025-03-26 - Session Log
Circulation/Circulation Research Writing Style Analysis
Request: Analyze writing style of 10 mitochondria-related articles from Circulation/Circulation Research journals, then rewrite a result section to match that style.
Style Analysis Key Findings
Journal Characteristics:
- Top-tier cardiology journals (impact factor: Circulation ~38, Circ Res ~17)
- Published by American Heart Association
- High standards for clinical translational relevance
Writing Style Features:
| Feature | Specific Pattern |
|---|---|
| Opening | Direct statement, no "We investigated..." clichés |
| Tense | Past tense for results description |
| Voice | Passive + active mixed; result-focused |
| Modifier use | Minimal "significantly", direct data presentation |
| Data format | Specific values with units (e.g., "by over 40%") |
| Paragraphs | One experiment/topic per paragraph |
| Figure citations | Parenthetical at sentence end, e.g., (Fig. 1A) |
Typical Sentence Patterns:
- "Diabetes reduced Kir6.1 and SUR1 expression in IFM by over 40% (p < 0.05)."
- "The levels of MAM-related proteins were significantly higher in diabetic heart homogenates..."
- "To determine the impact of diabetes mellitus on MAMs, we first examined..."
Rewritten Content Delivered
User provided a result section about mtDNase I and cardiomyocyte senescence. I rewrote it following Circulation style:
- Opening: "To determine whether clearance of damaged mitochondrial DNA..."
- Data presentation: Specific fold-changes (3-fold), percentages (40%, 58% → 28%), and absolute values (412 ± 56 vs 945 ± 89 arbitrary units)
- Organization: Grouped by outcome type (ROS → senescence markers → mitochondrial function → contractility)
- Figure legends: Standard format with subpanels, scale bars, and statistical notation
Example excerpt:
H/R challenge increased intracellular reactive oxygen species (ROS) levels by 3-fold compared to control cells (Fig. XB-C). mtDNase I expression reduced ROS accumulation by approximately 50% relative to vector controls.
Sources Referenced
- Circulation article: FUNDC1-MAMs in diabetic cardiomyopathy (10.1161/CIRCULATIONAHA.118.033552)
- Circulation Research article: mitoKATP in type I diabetes (PMC3594509)
User
- Name: Erwin
- Timezone: Asia/Shanghai